This webinar for wAF beneficiaries will comment the first stages in technology transfer-from TRL 2 to TRL6. What should the research team do to advance their technology and prove its commercial interest? We will follow a biotech/biomed team with a promising drug candidate and other practical examples.

The webinar will answer:
  • How to carry out a preliminary assessment of commercial interest. The Experimental Proof of Concept
  • Keeping the secret vs. Intellectual property protection
  • The Freedom to Operate analysis – will our development find external barriers?
  • From validation in the Lab to validation in the field
  • Finding funding: existing sources from EU grants to crowfunding
  • EU instruments for specialized coaching. Connections to useful networks (eg EEN).
  • Key Performance Indicators
  • Market and Business Readiness: Is our product/service really suited to go to the market?
Agenda

14:00 – 14:10: Connection start & Introduction

14:10 – 14:20 Presentation of the widerAdvance Facility

14:20 – 15.30 Webinar with intermediate coffee break

15.30 – 15:55: Round table discussion

15:55 – 16:00: Wrap up

MODERATOR: Alicia Boto (CSIC)